Religare Enterprises Limited (RELIGARE) Fair Value & Analysis
Financial Services · IN · Market cap ₹89.6B
Fair value as of: Jul 3, 2026
From 23 valuation models · updated today
Share price +12.9% over the past month.
Price vs Fair Value (12 months)
12‑month range ₹201.11 – ₹289.81 · fair‑value band ₹24.56 – ₹40.93 · the ₹262.85 price screens above the ₹32.75 fair value. As of Jul 3, 2026.
✦ Which stocks are undervalued right now? Check free Discover now →Analysis
Religare Enterprises Limited (RELIGARE) currently trades at ₹262.85, while our model-based Fair Value estimate is ₹32.75 — implying the stock looks roughly 87.5% overvalued today. We read business quality at 61/100 (solid quality), in the Financial Services sector. Bear case: priced above our estimate, the market already discounts strong expectations. Bull case: above-average quality can justify a premium — the entry price still matters most (evidence: medium).
Over the trailing twelve months, Religare Enterprises Limited generated revenue of ₹84.9B at a net margin of 1.0%. Revenue grew 22.1% year over year. It earns a return on equity of 2.0%. The balance sheet holds a net cash position of ₹12.1B. Fundamentals as of Jul 3, 2026
Key figures & financial health
More key figures
Figures from reported company fundamentals (EODHD) · as of Jul 3, 2026. TTM = trailing twelve months.
About the company
Religare Enterprises Limited, through its subsidiaries, provides various financial services in India and internationally. It operates through Investment and Financing Activities; Broking Related Activities; E-Governance; and Insurance segments. The company provides small and medium enterprise financing; and housing finance products comprising home-purchase, home construction, and home improvement loans. It also offers broking services in equity, currency, and commodity; and depository participant services, as well as operates as a NSDL-appointed enrolment agency for Aadhaar Unique Identification Number, and a mutual fund distributor. In addition, the company provides health, critical illness, personal accident, top-up coverage, international travel, and maternity insurance products, as well as group health and personal accident insurance for corporates. Further, the company engages in the permanent account number issuance; tax deduction and collection account number and e-TDS …
Revenue & earnings trend
FY2022 – FY2026 · reported fiscal years
Religare Enterprises Limited reported revenue of ₹84.3B in FY2026 versus ₹31.9B in FY2022, a compound +27.5%/yr. Reported net income was ₹860M in FY2026.
Is RELIGARE fairly valued? → Check now
Similar stocks
6 more Insurance - Life stocks, each showing price versus our Fair Value estimate (as of Jul 3, 2026).
| Stock | Price | Fair Value | vs Fair Value |
|---|---|---|---|
| Ping An Insurance (Group) Company 601318 | ¥51.98 | ¥103.96 | +100% |
| China Life Insurance Company 601628 | ¥36.89 | ¥73.78 | +100% |
| AIA Group AAGIY | $37.91 | $30.44 | -20% |
| Manulife Financial Corporation MFC | $40.34 | $76.10 | +89% |
| China Pacific Insurance (Group) Co CHPXF | $3.65 | $5.65 | +55% |
| Aflac Incorporated AFL | $117.11 | $71.78 | -39% |
Explore undervalued stocks
More undervalued Financial Services stocks →
Frequently asked questions
Is Religare Enterprises Limited (RELIGARE) undervalued?
What is the fair value of RELIGARE?
What is the quality score of RELIGARE?
What is the revenue of Religare Enterprises Limited (RELIGARE)?
What is the net profit margin of RELIGARE?
How we calculate Fair Value
Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.
Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.